Cargando…
Insulin-like growth factor II prevents oxidative and neuronal damage in cellular and mice models of Parkinson's disease
Oxidative distress and mitochondrial dysfunction, are key factors involved in the pathophysiology of Parkinson's disease (PD). The pleiotropic hormone insulin-like growth factor II (IGF-II) has shown neuroprotective and antioxidant effects in some neurodegenerative diseases. In this work, we de...
Autores principales: | Martín-Montañez, Elisa, Valverde, Nadia, Ladrón de Guevara-Miranda, David, Lara, Estrella, Romero-Zerbo, Yanina S., Millon, Carmelo, Boraldi, Federica, Ávila-Gámiz, Fabiola, Pérez-Cano, Ana M., Garrido-Gil, Pablo, Labandeira-Garcia, Jose Luis, Santin, Luis J., Pavia, Jose, Garcia-Fernandez, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379511/ https://www.ncbi.nlm.nih.gov/pubmed/34418603 http://dx.doi.org/10.1016/j.redox.2021.102095 |
Ejemplares similares
-
Neuronal Metabolism and Neuroprotection: Neuroprotective Effect of Fingolimod on Menadione-Induced Mitochondrial Damage
por: Gil, Antonio, et al.
Publicado: (2020) -
Impact of Glucocorticoid on a Cellular Model of Parkinson’s Disease: Oxidative Stress and Mitochondrial Function
por: Claros, Silvia, et al.
Publicado: (2021) -
IGF-II promotes neuroprotection and neuroplasticity recovery in a long-lasting model of oxidative damage induced by glucocorticoids
por: Martín-Montañez, E., et al.
Publicado: (2017) -
The Combination of Galanin (1–15) and Escitalopram in Rats Suggests a New Strategy for Alcohol Use Disorder Comorbidity with Depression
por: Cantero-García, Noelia, et al.
Publicado: (2022) -
Insulin-like Growth Factor II Prevents MPP+ and Glucocorticoid Mitochondrial-Oxidative and Neuronal Damage in Dopaminergic Neurons
por: Claros, Silvia, et al.
Publicado: (2021)